VanEck Vectors Pharmaceutical ETF (PPH)

60.36
Delayed Data
As of Jun 22
 +0.20 / +0.33%
Today’s Change
53.83
Today|||52-Week Range
64.65
+1.77%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Pharmaceutical ETF.

Performance

1 month+3.37% 3 years-4.23%
3 months+8.12% 5 years+7.92%
1 year+2.34% Since inception+10.66%
Data through 06/23/2018

Quote Details

Previous close$60.16
Open day’s range60.27 – 60.48
Net asset value (NAV)60.35 (06/22/2018)
Daily volume45,221
Average volume (3 months)49,923
Data as of 4:00pm ET, 06/22/2018

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+7.92%+14.29%
Expense Gross exp ratio0.40%1.29%
Risk 5 year sharpe ratio0.520.90
Net assets$257.5M$3.0B
Average market cap$43.0B$28.5B
Average P/E22.525.2
Dividend / Share--0.30%

Competitors

FHLC Fidelity® MSCI Health Care Index ETF
XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 6.36%
AZN AstraZeneca5.50%
MRK Merck5.47%
GSK GlaxoSmithKline5.44%
JAZZ Jazz Pharmaceuticals PLC5.24%
TEVA Teva Pharmaceutical5.08%
PFE Pfizer5.00%
LLY Eli Lilly and Co4.95%
SNY Sanofi4.80%
NVO Novo Nordisk4.70%